| Literature DB >> 30037332 |
Holly Q Bennett1, Sam Norton2, Frances Bunn3, Louise Robinson4, Greta Rait5, Claire Goodman3, Carol Brayne1, Fiona E Matthews6,7.
Abstract
BACKGROUND: The presence of concomitant medical conditions in people with dementia is common. Dementia may be related to differential use of health, social and informal care.Entities:
Keywords: Care; Change over time; Co-morbidity; Dementia
Mesh:
Year: 2018 PMID: 30037332 PMCID: PMC6056993 DOI: 10.1186/s12916-018-1105-8
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Weighted prevalence of dementia and the target health conditions of those living in the community aged 75 and above for CFAS I and CFAS II. See methods for description of weights
| Health condition | n | Weighted % | 95% CI |
|---|---|---|---|
| CFAS I 10-year follow-up ( | |||
| Dementia | 83 | 6.4 | 3.9–10.3 |
| Stroke | 160 | 9.7 | 7.6–12.4 |
| Diabetes | 152 | 8.1 | 6.3–10.4 |
| Visual impairment | 178 | 12.5 | 9.3–16.5 |
| Target comorbidities | 416 | 26.3 | 22.3–30.6 |
| CFAS II baseline ( | |||
| Dementia | 277 | 8.5 | 7.5–9.6 |
| Stroke | 377 | 10.4 | 9.4–11.4 |
| Diabetes | 540 | 14.5 | 13.3–15.7 |
| Visual impairment | 602 | 17.3 | 16.0–18.6 |
| Target comorbidities | 1294 | 34.5 | 33.0–36.1 |
Weighted prevalence of the target comorbidities separated by dementia status for those aged 75 and above living in the community for CFAS I and CFAS II. See methods for description of weights
| Dementia | No dementia | |||||
|---|---|---|---|---|---|---|
| Health condition | n | Weighted % | 95% CI | n | Weighted % | 95% CI |
| CFAS I 10-year follow-up ( | ||||||
| Stroke | 17 | 22.6 | 14.0–34.4 | 143 | 9.7 | 8.3–11.4 |
| Diabetes | 13 | 15.6 | 6.6–34.8 | 139 | 8.6 | 7.3–10.1 |
| Visual impairment | 19 | 21.7 | 13.5–32.9 | 159 | 11.4 | 9.7–13.2 |
| Target comorbidities | 41 | 47.6 | 36.5–58.8 | 375 | 25.4 | 23.2–27.7 |
| CFAS II baseline ( | ||||||
| Stroke | 47 | 17.9 | 13.3–23.8 | 330 | 9.7 | 8.8–10.8 |
| Diabetes | 42 | 16.2 | 11.8–21.9 | 498 | 14.3 | 13.2–15.6 |
| Visual impairment | 39 | 16.7 | 12.1–22.6 | 563 | 17.3 | 16.0–18.7 |
| Target comorbidities | 100 | 35.7 | 29.7–42.1 | 1194 | 35.1 | 33.5–36.8 |